Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / COLL - Collegium Pharmaceutical: No Longer Speculative After A Year Of Profitability


COLL - Collegium Pharmaceutical: No Longer Speculative After A Year Of Profitability

  • Despite the COVID -19 pandemic, Collegium Pharmaceutical had an impressive 2020. The company recorded a full year of profitability and commercial progress.
  • Collegium is off to a good start in 2021, with the company reporting Xtampza ER's quarter-to-date total script volume being up 13% over Q4.
  • Collegium was able to grow in the middle of the pandemic without a massive increase in OpEx. As a result, I am switching COLL out of my speculative portfolio.

For further details see:

Collegium Pharmaceutical: No Longer Speculative After A Year Of Profitability
Stock Information

Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com

Menu

COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...